Abstract
Background:
One of the strongest risk factors of cardiovascular disease is a high concentration of low-density lipoprotein cholesterol (LDL-C); thus, the accurate measurement of LDL-C concentration in children is important. The aim of this study was to compare the concentration of LDL-C measured by direct method and the LDL-C concentration estimated by different formulas with the modified β-quantification method in children with type 1 diabetes.
Methods:
Thirty-one serum samples received from diabetic children (15/18; M/F) and 26 serum samples taken from nondiabetic children (18/14; M/F) were used in the study. LDL-C concentrations were determined by direct enzymatic method (LDL-CD) and the modified β-quantification method (LDL-CmBQ). The concentration of LDL-C was also calculated by different formulas.
Results:
The results of LDL-CmBQ and LDL-CD correlated. However, the correlation coefficient obtain in the nondiabetic samples was much higher (r=0.927; p<0.001) than the correlation coefficient for LDL-CmBQ and LDL-CD concentration obtained in the diabetic samples (r=0.691; p<0.001). Additionally, the coefficients of correlation between the LDL-CmBQ concentration and the LDL-C concentrations calculated by different formulas were lower in diabetic (range: 0.514–0.693) than in nondiabetic samples (range: 0.834–0.937). Bland-Altman plots showed much higher confidence intervals for 95% limits of agreement for the differences between LDL-CmBQ and LDL-CD as well as for the differences between LDL-CmBQ and LDL-C estimated by different formulas for samples from the diabetic samples compared with nondiabetic samples.
Conclusions:
The limitations of methods measurement and of each of the formulas should be taken into account when a medical decision to lower LDL-C is made in the treatment of diabetic children.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Dabelea D, Bell RA, D’Agostino RB, Imperatore G, Johansen JM, Linder B, et al. Incidence of diabetes in youth in the United States. J Am Med Assoc 2007;297:2716–24.10.1001/jama.297.24.2716Search in Google Scholar PubMed
2. National Cholesterol Education Program (NCEP): highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495–501.10.1542/peds.89.3.495Search in Google Scholar
3. Contois JH, Warnick GR, Sniderman AD. Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement. J Clin Lipidol 2011;5:264–72.10.1016/j.jacl.2011.05.004Search in Google Scholar PubMed
4. For Eponig, Health C, Children Rrin. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128(Suppl 5):S213.10.1542/peds.2009-2107CSearch in Google Scholar PubMed PubMed Central
5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486–97.10.1001/jama.285.19.2486Search in Google Scholar PubMed
6. Homma TK, Endo CM, Saruhashi T, Mori AP, de Noronha RM, Monte O, et al. Dyslipidemia in young patients with type 1 diabetes mellitus. Arch Endocrinol Metab 2015;59:215–9.10.1590/2359-3997000000040Search in Google Scholar PubMed
7. Cole TG, Ferguson CA, Gibson DW, Nowatzke WL. Optimization of beta-quantification methods for high-throughput applications. Clin Chem 2001;47:712–21.10.1093/clinchem/47.4.712Search in Google Scholar
8. Oliveira MJ, van Deventer HE, Bachmann LM, Warnick GR, Nakajima K, Nakamura M, et al. Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays. Clin Chim Acta 2013;423:135–40.10.1016/j.cca.2013.04.009Search in Google Scholar PubMed PubMed Central
9. Saiedullah M, Sarkar A, Kamaluddin SM, Begum S, Hayat S, Rahman MR, et al. Friedewald’s formula is applicable up to serum triacylglycerol to total cholesterol ratio of two in Bangladeshi population. Anwer Khan Mod Med Coll J 2011;2:21–5.10.3329/akmmcj.v2i2.8168Search in Google Scholar
10. Anandaraja S, Narang R, Godeswar R, Laksmy R, Talwar KK. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol 2005;102:117–20.10.1016/j.ijcard.2004.05.009Search in Google Scholar PubMed
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.10.1093/clinchem/18.6.499Search in Google Scholar
12. de Cordova CM, de Cordova MM. A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort. Ann Clin Biochem 2013;50(Pt 1):13–9.10.1258/acb.2012.011259Search in Google Scholar
13. Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis 2010;9:1.10.1186/1476-511X-9-52Search in Google Scholar
14. Vujovic A, Kotur-Stevuljevic J, Spasic S, Bujisic N, Martinovic J, Vujovic M, et al. Evaluation of different formulas for LDL-C calculation. Lipids Health Dis 2010;9:27.10.1186/1476-511X-9-27Search in Google Scholar
15. Puavilai W, Laorugpongse D, Deerochanawong C, Muthapongthavorn N, Srilert P. The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: a pilot study. J Med Assoc Thai 2009;92:182–7.Search in Google Scholar
16. Planella T, Cortes M, Martinez-Bru C, Gonzalez-Sastre F, Ordonez-Llanos J. Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia. Clin Chem 1997;43:808–15.10.1093/clinchem/43.5.808Search in Google Scholar
17. Wagner AM, Zapico E, Bonet R, Perez A, Ordonez-Llanos J. The effect of VLDL particles on the accuracy of a direct LDL-cholesterol method in type 2 diabetic patients. Clin Biochem 2003;36:177–83.10.1016/S0009-9120(03)00006-7Search in Google Scholar
18. Hattori Y, Suzuki M, Tsushima M, Yoshida M, Tokunaga Y, Wang Y, et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis 1998;138:289–99.10.1016/S0021-9150(98)00034-3Search in Google Scholar
19. Ciach E, Bobilewicz D, Kmin E. Porównanie stężeń cholesterolu frakcji LDL wyliczonych z równania Friedewalda i oznaczonych metodą bezpośrednią Cholesterol LDL – direct measurements and calculated from Friedewald formula. Diagn Lab 2011;47:419–23.Search in Google Scholar
20. Ahmadi S-A, Boroumand M-A, Gohari-Moghaddam K, Tajik P, Dibaj S-M. The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med 2008;11:318–21.Search in Google Scholar
21. Harris N, Neufeld EJ, Newburger JW, Ticho B, Baker A, Ginsburg GS, et al. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem 1996;42(8 Pt 1):1182–8.10.1093/clinchem/42.8.1182Search in Google Scholar
22. Meeusen JW, Lueke AJ, Jaffe AS, Saenger AK. Validation of a proposed novel equation for estimating LDL cholesterol. Clin Chem 2014;60:1519–23.10.1373/clinchem.2014.227710Search in Google Scholar PubMed
23. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41:1414–20.10.1093/clinchem/41.10.1414Search in Google Scholar
24. Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocrinol Metab 2014;18:502–4.10.4103/2230-8210.137496Search in Google Scholar PubMed PubMed Central
25. Bugajska J, Berska J, Sztefko K. Przydatność wzoru Friedewalda w pediatrii. Diagn Lab 2008;217–23.Search in Google Scholar
26. Loh TP, Metz MP. Trends and physiology of common serum biochemistries in children aged 0–18 years. Pathology 2015;47:452–61.10.1097/PAT.0000000000000274Search in Google Scholar PubMed
27. Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, et al. A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects. Atherosclerosis 2012;225:208–15.10.1016/j.atherosclerosis.2012.08.022Search in Google Scholar PubMed
28. Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem 2010;56:977–86.10.1373/clinchem.2009.142810Search in Google Scholar PubMed PubMed Central
29. Esteban-Salan M, Aguilar-Doreste JA, Arranz-Pena ML, Juve-Cuxart S, Gich-Salarich I, Zapico-Muniz E, et al. Multicentric evaluation of the homogeneous LDL-cholesterol Plus assay: comparison with beta-quantification and Friedewald formula. Clin Biochem 2008;41:1402–9.10.1016/j.clinbiochem.2008.07.014Search in Google Scholar PubMed
30. Kamal AH, Hossain M, Chowdhury S, Mahmud NU. A comparison of calculated with direct measurement of low density lipoprotein cholesterol level. J Chittagong Med Coll Teach Assoc 2009;20:19–23.10.3329/jcmcta.v20i2.5621Search in Google Scholar
31. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002;48:236–54.10.1093/clinchem/48.2.236Search in Google Scholar
32. Ticho BS, Neufeld EJ, Newburger JW, Harris N, Baker A, Rifai N. Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. Arch Pediatr Adolesc Med 1998;152:787–91.10.1001/archpedi.152.8.787Search in Google Scholar PubMed
33. Ordóñez-Llanos J, Wägner AM, Bonet-Marqués R, Sánchez-Quesada JL, Blanco-Vaca F, González-Sastre F. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C plus assay? Clin Chem 2001;47:124–6.10.1093/clinchem/47.1.124Search in Google Scholar
34. Nauck M, Graziani MS, Bruton D, Cobbaert C, Cole TG, Lefevre F, et al. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem 2000;46:506–14.10.1093/clinchem/46.4.506Search in Google Scholar
35. Avaialble at: www.orthoclinical.com/en-us/customer-support/technical-documents.Search in Google Scholar
36. Stenman U-H. Immunoassay standardization: is it possible, who is responsible, who is capable? Clin Chem 2001;47:815–20.10.1093/clinchem/47.5.815Search in Google Scholar
37. Sztefko K. Problemy standaryzacji i kalibracji metod immunochemicznych Standardization and calibration of immunochemistry methods – current problems. Diagn Lab 2011;47:7–15.Search in Google Scholar
38. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007;9:233–45.10.1111/j.1463-1326.2006.00595.xSearch in Google Scholar PubMed
39. Szutowicz A. Hiperglikacja białek wewnątrz i zewnątrzkomórkowych; marker czy aktywny element patomechanizmów cukrzycy [Hyperglycation of extra and intracellular proteins; marker or active element of diabetic pathomechanisms]. Diagn Lab 2015;51:213–20.10.5604/01.3001.0008.2261Search in Google Scholar
40. Yegin A, Ozben T, Yegin H. Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1995;25:157–61.10.1007/BF02592559Search in Google Scholar PubMed
41. Fruchart J-C, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, et al. The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008;102(10 Suppl):1K–34K.10.1016/j.amjcard.2008.10.002Search in Google Scholar
42. Sibal L, Neely RD, Jones A, Home PD. Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without type 1 diabetes. Diabet Med 2010;27:37–45.10.1111/j.1464-5491.2009.02888.xSearch in Google Scholar PubMed
43. Kapoor R, Chakraborty M, Singh N. A leap above Friedewald formula for calculation of low-density lipoprotein-cholesterol. J Lab Physicians 2015;7:11–6.10.4103/0974-2727.154780Search in Google Scholar PubMed PubMed Central
44. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol 2004;44:720–32.10.1016/j.jacc.2004.07.001Search in Google Scholar PubMed
45. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006;98:1363–8.10.1016/j.amjcard.2006.06.032Search in Google Scholar PubMed
46. Anwar M, Khan DA, Khan FA. Comparison of friedewald formula and modified friedewald formula with direct homogeneous assay for low density lipoprotein cholesterol estimation. J Coll Physicians Surg Pak 2014;24:8–12.Search in Google Scholar
Supplemental Material:
The online version of this article (DOI: 10.1515/dx-2016-0034) offers supplementary material, available to authorized users.
©2017 Walter de Gruyter GmbH, Berlin/Boston
